CUPERTINO, Calif., June 6 DURECT Corporation(Nasdaq: DRRX) announced today that management is scheduled to present atthree upcoming life sciences conferences in New York, NY.
A live audio webcast of the presentations will be available by accessingDURECT's homepage at http://www.durect.com and clicking "Investor Relations."If you are unable to participate during the live webcast, the call will bearchived on DURECT's website under Audio Archive in the "Investor Relations"section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical companydeveloping pharmaceutical systems based on its proprietary drug deliveryplatform technologies. The Company currently has a number of late-stagepharmaceutical products in development addressing large markets in painmanagement, with a number of research programs underway targeting chronicdisease and other therapeutic areas. For more information, please visithttp://www.durect.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)-- Needham & Company's Biotechnology and Medical Technology Conference on Thursday, June 12th at 11:30 a.m. EDT. -- Leerink Swann's Pain Roundtable Conference, on Monday, June 23rd at 12:45 p.m. EDT. -- Jefferies' 2nd Annual Healthcare Conference on Thursday, June 26th at 10:45 a.m. EDT.
SOURCE DURECT Corporation